Insulet Corp (PODD)
165.90
-11.63
(-6.55%)
USD |
NASDAQ |
May 10, 16:00
166.49
+0.59
(+0.36%)
Pre-Market: 20:00
Insulet Gross Profit (TTM): 1.226B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.226B |
December 31, 2023 | 1.160B |
September 30, 2023 | 1.016B |
June 30, 2023 | 911.00M |
March 31, 2023 | 836.40M |
December 31, 2022 | 805.60M |
September 30, 2022 | 801.50M |
June 30, 2022 | 801.90M |
March 31, 2022 | 794.30M |
December 31, 2021 | 752.10M |
September 30, 2021 | 700.00M |
June 30, 2021 | 663.10M |
March 31, 2021 | 622.90M |
December 31, 2020 | 582.30M |
September 30, 2020 | 555.30M |
June 30, 2020 | 526.60M |
March 31, 2020 | 500.50M |
December 31, 2019 | 480.30M |
September 30, 2019 | 456.54M |
June 30, 2019 | 435.41M |
March 31, 2019 | 401.08M |
December 31, 2018 | 370.20M |
September 30, 2018 | 339.40M |
June 30, 2018 | 311.05M |
March 31, 2018 | 293.62M |
Date | Value |
---|---|
December 31, 2017 | 277.20M |
September 30, 2017 | 258.60M |
June 30, 2017 | 240.62M |
March 31, 2017 | 226.43M |
December 31, 2016 | 211.09M |
September 30, 2016 | 192.14M |
June 30, 2016 | 168.07M |
March 31, 2016 | 148.13M |
December 31, 2015 | 133.27M |
September 30, 2015 | 111.79M |
June 30, 2015 | 118.26M |
March 31, 2015 | 123.51M |
December 31, 2014 | 127.13M |
September 30, 2014 | 139.63M |
June 30, 2014 | 128.99M |
March 31, 2014 | 120.05M |
December 31, 2013 | 112.40M |
September 30, 2013 | 104.70M |
June 30, 2013 | 101.70M |
March 31, 2013 | 97.20M |
December 31, 2012 | 92.34M |
September 30, 2012 | 87.10M |
June 30, 2012 | 81.27M |
March 31, 2012 | 73.48M |
December 31, 2011 | 66.71M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
435.41M
Minimum
Jun 2019
1.226B
Maximum
Mar 2024
731.39M
Average
726.05M
Median
Gross Profit (TTM) Benchmarks
Stryker Corp | 13.38B |
Tandem Diabetes Care Inc | 379.46M |
Abbott Laboratories | 22.22B |
ResMed Inc | 2.557B |
Integra Lifesciences Holdings Corp | 858.70M |